Category:Daniel Fred ORTWINE of Williamsburg MI (US)

Daniel Fred ORTWINE of Williamsburg MI (US)

Executive Summary

Daniel Fred ORTWINE of Williamsburg MI (US) is an inventor who has filed 2 patents. Their primary areas of innovation include HETEROCYCLIC COMPOUNDS (macromolecular compounds (2 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS (1 patents), and they have worked with companies such as Genentech, Inc. (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C07D401/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 2 patents
• A61K31/18 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P25/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C07C311/51 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
• C07D211/96 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D277/44 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D277/82 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D295/26 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D471/04 (Ortho-condensed systems): 1 patents
• C07D487/04 (Ortho-condensed systems): 1 patents
• C07D498/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• A61K31/454 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K31/506 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P17/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P29/00 (Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]): 1 patents
• C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D405/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D413/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D417/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents

Companies

List of Companies

• Genentech, Inc.: 2 patents

Collaborators

• Steven John MCKERRALL of San Francisco CA (US) (2 collaborations)
• Philippe BERGERON of Redwood City CA (US) (2 collaborations)
• Marc KSCHONSAK of South San Francisco CA (US) (1 collaborations)
• Jian Mehr-Dean PAYANDEH of Alameda CA (US) (1 collaborations)
• Benjamin Douglas SELLERS of Larkspur CA (US) (1 collaborations)
• John C. TELLIS of San Francisco CA (US) (1 collaborations)
• Matthew VOLGRAF of Oakland CA (US) (1 collaborations)
• Claudio CIFERRI of Oakland CA (US) (1 collaborations)
• Peter Scott DRAGOVICH of San Diego CA (US) (1 collaborations)
• Ramsay BEVERIDGE (1 collaborations)
• Elise GHIRO (1 collaborations)
• Kwong Wah LAI (1 collaborations)
• Guqin SHI (1 collaborations)